NCT01035515View on ClinicalTrials.gov

BIIB014 Cardiovascular Monitoring Study

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Healthy

Interventions

DRUG

Placebo

Single dose oral capsule placebo comparator

DRUG

BIIB014 50mg

Single dose oral capsule 50mg BIIB014

DRUG

BIIB014 100mg

Single dose oral capsule 100mg BIIB014

Trial Locations (1)

66211

Quintiles Inc, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY